Unilever Outlines Strategy Behind $68 Billion GSK Consumer Health Care Bid

The company has so far had three bids rejected as it aims to extend its offer in health, beauty and hygiene

Adweek's annual #Brandweek summit will explore the ideas behind breakthrough successes, discuss solutions to pressing challenges and explore new opportunities in the Metaverse. Join leaders from Alo Yoga, Hyundai Motor America, Frito-Lay and more, Sept. 12–16 in Miami. Sign up early to save.

Unilever has outlined why it has tabled three bids, with the latest at around $68 billion, for the Consumer Healthcare division of GlaxoSmithKline (GSK). Following an “extensive” review, the British owner of Ben & Jerry’s, PG Tips, Dove and Lipton Tea has decided that its strategic direction should be to “materially expand” its health, beauty and hygiene offer.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in